AstraZeneca (NasdaqGS:AZN) Q1 2026 Earnings call April 29, 2026 09:30 AM ET Company ParticipantsAradhana Sarin - Executive Director and CFODave Fredrickson - EVP of Oncology Business UnitJoris Silon - Head of Investor RelationsMarc Dunoyer - CEO of Alexion and Chief Strategy OfficerPascal Soriot - Executive Director and CEORuud Dobber - EVP of BioPharmaceuticals Business UnitSharon Barr - EVP of BioPharmaceuticals R&DSusan Galbraith - EVP of Oncology R&DConference Call ParticipantsChristopher Lyrhem - Analy ...